Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities
Net loss	$ (152,060)	$ (167,874)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	29,998	19,096
Amortization of acquired intangible assets	11,400	0
Amortization of premiums and accretion of purchase discounts on investment securities	0	19
Non-cash settlement expense	1,226	0
Non-cash lease expense	13,346	9,348
Stock-based compensation	198,204	171,185
Change in fair value of warrants and preferred stock of related party equity investment	(166)	(3,235)
Revaluation of contingent consideration	550	0
Other non-cash items	449	8
Non-cash expense recovery	(1,310)	(722)
Changes in operating assets and liabilities:
Accounts receivable	(125,440)	4,941
Inventory	(11,903)	(9,528)
Operating lease right-of-use assets	1,368	0
Prepaid expenses and other assets	(9,479)	(6,595)
Accounts payable	35,618	6,979
Accrued compensation	58,899	25,787
Operating lease liabilities	(11,971)	(9,307)
Other accrued liabilities	43,123	40,464
Deferred revenue	14,670	1,460
Other long-term liabilities	(1,574)	0
Net cash provided by operating activities	94,964	82,026
Investing activities
Proceeds from maturity of investments	0	7,000
Purchases of property and equipment, net	(85,566)	(47,712)
Investment in related party	(10,000)	0
Net cash used in investing activities	(95,566)	(40,712)
Financing activities
Proceeds from exercise of stock options	4,736	884
Cash paid to satisfy statutory withholding requirement for net settlement of cashless stock option exercises	(5,097)	0
Proceeds from the issuance of common stock under the employee stock purchase plan	16,430	12,236
Stock issuance costs	(105)	0
Net cash provided by financing activities	15,964	13,120
Net change in cash, cash equivalents and restricted cash	15,362	54,434
Cash, cash equivalents and restricted cash, beginning of period	1,076,140	945,587
Cash, cash equivalents and restricted cash, end of period	1,091,502	1,000,021
Supplemental disclosure of cash flow information:
Cash paid for interest	1,782	2,034
Non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accruals	15,349	(4,819)
Acquisition of warrants and warrants receivable	7,162	0
Consideration for business combination	30	0
Issuance of common stock for IPR&D milestone	774	0
Issuance of common stock for bonuses	47,026	32,875
Stock-based compensation included in capitalized software development costs	994	1,397
Foresight Diagnostics, Inc.
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of acquired intangible assets	11,416	$ 0
Revaluation of contingent consideration	$ 2,100